HPV vaccine vs placebo for stubborn skin warts
Treatments studied
Part of Infections, Skin clinical trials.
This study tests whether an HPV vaccine can help shrink or clear cutaneous (skin) warts that have not responded to prior treatments. Participants get the study vaccine or a placebo to compare results and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign consent in writing
- You are age 18 or older
- You have skin warts confirmed by a clinician
- Your skin warts have already been treated before
- Your last wart treatment was more than 4 weeks ago
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests giving a Candida antigen plus a bivalent HPV vaccine to help shrink or clear multiple common skin warts. It may help people with warts on different body areas, with different sizes or how long they’ve had them.
This trial tests whether applying heat combined with a common disinfectant (hydrogen peroxide) can safely and effectively remove viral skin warts. It may be an option if you have common, plantar, or genital warts and are between 16 and 65 years old.
This study tests whether a single dose of the HPV vaccine is enough to protect against the viruses that cause several cancers. You will have the vaccine and some small tissue samples taken to see how your immune system responds.
This trial tests whether getting the HPV vaccine after treatment for vulvar high-grade lesions can help prevent the lesions from coming back. It is for women who have not been vaccinated before and are about to have treatment for this condition.
This study looks at how well the HPV vaccine works in women who have already been exposed to the virus through sexual activity. It aims to understand the immune response and potentially improve protection against HPV-related cancers.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
Hear when a new Warts trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.